Emmanuelle Clérin
- Ophthalmology top 1%
-
- Photoreceptor and optogenetics research 5
- Neuroscience and Neuropharmacology Research 3
- Developmental Neuroscience top 5%
- Molecular Biology top 10%
- Retinal Development and Disorders 22
- Redox biology and oxidative stress 6
- bioluminescence and chemiluminescence research 4
- Connexins and lens biology 3
- Neurology top 10%
-
- Advanced Fluorescence Microscopy Techniques 4
-
- Photochromic and Fluorescence Chemistry 3
- Co-authors
- Thierry LéveillardJosé‐Alain SahelSaddek Mohand‐SaïdManuel SimonuttiDeniz DalkaraLeah C. ByrneOlivier PochValérie Forster
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Emmanuelle Clérin
29 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 70
- Ophthalmology 381
- Cellular and Molecular Neuroscience 557
- Developmental Neuroscience 90
- Molecular Biology 1.1k
- Neurology 86
Countries citing papers authored by Emmanuelle Clérin
This map shows the geographic impact of Emmanuelle Clérin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Clérin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Clérin more than expected).
Fields of papers citing papers by Emmanuelle Clérin
This network shows the impact of papers produced by Emmanuelle Clérin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Clérin. The network helps show where Emmanuelle Clérin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emmanuelle Clérin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2021 | 14 | |
| 3 | 2021 | 7 | |
| 4 | The development of a therapy for retinitis pigmentosa based on the combined administration of the two products encoded by the nucleoredoxin like-1 gene | 2018 | 1 |
| 5 | The combined administration of the two products encoded by the nucleoredoxin-like-I gene stabilizes vision in a mouse model of retinitis pigmentosa | 2017 | 1 |
| 6 | 2016 | 42 | |
| 7 | The thioredoxin RdCVFL protects against photo-oxidative retinal damage | 2015 | 1 |
| 8 | 2015 | 36 | |
| 9 | 2014 | 12 | |
| 10 | 2014 | 3 | |
| 11 | 2013 | 6 | |
| 12 | 2012 | 22 | |
| 13 | AAV-mediated Delivery of Rod-derived Cone Viability Factor in a Mouse Model of Retinal Degeneration | 2011 | 1 |
| 14 | 2011 | 9 | |
| 15 | 2010 | 62 | |
| 16 | 2009 | 130 | |
| 17 | 2004 | 330 | |
| 18 | 1997 | 6 | |
| 19 | 1991 | 41 | |
| 20 | 1991 | 61 |
About Emmanuelle Clérin
Emmanuelle Clérin is a scholar working on Biophysics, Cellular and Molecular Neuroscience and Developmental Neuroscience, having authored 29 papers that have together received 1.3k indexed citations. Recurring topics across this work include Retinal Development and Disorders (22 papers), Redox biology and oxidative stress (6 papers), Photoreceptor and optogenetics research (5 papers), bioluminescence and chemiluminescence research (4 papers), Advanced Fluorescence Microscopy Techniques (4 papers), Neuroscience and Neuropharmacology Research (3 papers), Connexins and lens biology (3 papers) and Photochromic and Fluorescence Chemistry (3 papers). The work is most often cited by research in Ophthalmology (381 citations), Cellular and Molecular Neuroscience (557 citations) and Developmental Neuroscience (90 citations). Emmanuelle Clérin has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Thierry Léveillard, José‐Alain Sahel, Saddek Mohand‐Saïd, Manuel Simonutti, Deniz Dalkara, Leah C. Byrne, Olivier Poch, Valérie Forster, Ying Yang and Olivier Lorentz. Their work appears in journals such as Cell, Journal of Clinical Investigation and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.